Christian Dillon

Christian joined PhoreMost in June 2021 as Vice President of Biology and was subsequently promoted to Chief Scientific Officer at the end of 2021. Prior to this, he served as Associate Director at Cancer Research UK’s Therapeutic Discovery Laboratories where he acted as programme director for a number of drug discovery alliances with pharmaceutical partners. As part of the senior leadership team at CRUK, he oversaw the progression of its portfolio of small molecule and therapeutic antibodies, three of which have recently progressed to clinical development. Additionally, Christian has led scientific negotiations with commercial partners resulting in several high-value partnerships for CRUK.